Also Lejeune et al, (2006) [45] reported a case study of a patient with a metastatic melanoma of the leg who experienced sustained regression of skin metastases upon continuous single treatment with the cyclooxygenase-2 inhibitor Rofecoxib. Here, PTGS2 is linked to metastatic melanoma.